Mason Street Advisors LLC Acquires Shares of 2,419 Analogic Corp. (ALOG)
Mason Street Advisors LLC acquired a new stake in Analogic Corp. (NASDAQ:ALOG) during the second quarter, Holdings Channel reports. The institutional investor acquired 2,419 shares of the company’s stock, valued at approximately $192,000.
Other hedge funds also recently made changes to their positions in the company. Tower Research Capital LLC TRC increased its position in Analogic Corp. by 976.0% in the second quarter. Tower Research Capital LLC TRC now owns 1,302 shares of the company’s stock worth $103,000 after buying an additional 1,181 shares in the last quarter. PineBridge Investments L.P. boosted its stake in Analogic Corp. by 3.5% in the second quarter. PineBridge Investments L.P. now owns 1,570 shares of the company’s stock worth $125,000 after buying an additional 53 shares during the last quarter. Profund Advisors LLC boosted its stake in Analogic Corp. by 2.5% in the second quarter. Profund Advisors LLC now owns 2,748 shares of the company’s stock worth $218,000 after buying an additional 68 shares during the last quarter. AHL Partners LLP acquired a new stake in Analogic Corp. during the second quarter worth approximately $226,000. Finally, BlackRock Inc. boosted its stake in Analogic Corp. by 274.0% in the second quarter. BlackRock Inc. now owns 3,216 shares of the company’s stock worth $256,000 after buying an additional 2,356 shares during the last quarter. 99.81% of the stock is owned by institutional investors.
Shares of Analogic Corp. (NASDAQ:ALOG) opened at 85.59 on Thursday. The company has a market capitalization of $1.06 billion, a PE ratio of 89.16 and a beta of 0.92. The company has a 50-day moving average price of $89.33 and a 200-day moving average price of $83.72. Analogic Corp. has a 52 week low of $68.71 and a 52 week high of $94.39.
Analogic Corp. (NASDAQ:ALOG) last released its earnings results on Wednesday, September 21st. The company reported $1.02 EPS for the quarter, missing analysts’ consensus estimates of $1.17 by $0.15. Analogic Corp. had a return on equity of 7.33% and a net margin of 2.38%. The company earned $138.10 million during the quarter, compared to analysts’ expectations of $139.03 million. During the same period in the prior year, the company posted $1.28 earnings per share. The company’s revenue was down 10.6% on a year-over-year basis. Analysts predict that Analogic Corp. will post $4.04 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, October 12th. Stockholders of record on Thursday, September 1st were paid a $0.10 dividend. The ex-dividend date was Wednesday, September 28th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.47%. Analogic Corp.’s dividend payout ratio is currently 41.24%.
A number of research firms have recently commented on ALOG. Zacks Investment Research cut Analogic Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, September 27th. Brean Capital restated a “buy” rating and issued a $100.00 price objective (up from $90.00) on shares of Analogic Corp. in a research note on Thursday, September 22nd.
In other news, CEO James W. Green sold 2,000 shares of the stock in a transaction on Monday, October 10th. The stock was sold at an average price of $88.34, for a total value of $176,680.00. Following the sale, the chief executive officer now directly owns 36,531 shares of the company’s stock, valued at $3,227,148.54. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO James W. Green sold 500 shares of the stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $91.25, for a total value of $45,625.00. The disclosure for this sale can be found here. 2.40% of the stock is owned by insiders.
About Analogic Corp.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies to advance the practice of medicine and save lives. The Company operates through three business segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Corp. (NASDAQ:ALOG).
Receive News & Ratings for Analogic Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corp. and related companies with MarketBeat.com's FREE daily email newsletter.